Global Journal of Medical Research, F: Diseases, Volume 22 Issue 6

clinical and laboratory features among the children in Bangladesh A lower middle-income country. Global Pediatric Health 2020; 7: 1-15. 16. CLSI. Sweat Testing: Sample Collection and Quantitative Chloride Analysis; Approved Guideline – Third Edition. CLSI document C34-A3 (ISBN 1- 56238-713-8). Wayne, PA: Clinical and Laboratory Standards Institute; 2009. 17. Philip MF, Beryl JR. Guidelines for diagnosis of cystic fibrosis in new borns through older adults: Cystic Fibrosis Foundation Consensus Report. J Pediatr 2008; 53: S4 – S14. 18. Kabra SK, Kabra M, Lodha R, Shastri S, Ghosh S, Pandey RM et al. Clinical profile and frequency of delta f508 mutation in Indian children in Cystic Fibrosis. Indian Pediatr. 2003; 40: 612- 619. 19. Raina MA, Khan MS, Malik SA, Raina ABH, Makhdoomi JI et al. Assessment of correlation between sweat chloride levels and clinical features of cystic fibrosis patients. J Clin Diagn Res. 2018; 10(12): BC01 – BC06. 20. Kawoosa MS, Bhat MA, Ali SW, Hafeez I, Shastri S. Clinical and Mutation profile of Cystic fibrosis in Jammu and Kashmir. Indian Pediatrics. 2014; 51: 185 - 189. 21. Singh M, Prasad R, Kumar L. Cystic fibrosis in North Indian children. Indian J Pediatr. 2002; 69: 622 – 629. 22. Fitz Simmons. The changing epidemiology of cystic fibrosis. J Pediatr 1993; 122: 1 – 9. 23. Al Mahroos F. Cystic fibrosis in Bahrain – incidence, phenotype and outcome. J Trop Pediatr. 1998; 44: 35 – 39. 24. Desgeorges M, Megarbane A, Guittard C, Carles S, Loiselet J, Dmaille J. Cystic fibrosis in Lebanon: distribution of CFTR mutations among Arab communities. Hum Genet. 1997; 100: 279 – 283. 25. Mona M. El-Falaki, Walaa A. Shahin, Noussa R. El- Basha, Aliaa A. Ali, Dina A. Mehaney, Mona M. El- Attai. Profile of cystic fibrosis in a single referral centre in Egypt. J Adv Res. 2014; 5(5): 563- 568. 26. Farahmand F, Khalili M, Shahbaznejad L, Hibrod- Mobarakeh A, Sani MN, Khodad A, et al. Clinical presentation cystic fibrosis at the time of diagnosis: a multicenter study in a region without new born screening. Turk J gastroenterol. 2013; 24 (6): 541 – 545. 27. Shah U, Moatter T, Bhutta ZA. Profile and factors determining outcome in a cohort of cystic fibrosis patients seen at Aga Khan university hospital, Karachi, Pakistan. Journal of tropical pediatrics. 2006; 52: 132- 135. 28. Aziz DA, Billo AG, Qureshi A, Khalid M, Kirmani S. Clinical and laboratory profile of cystic fibrosis: Experience of a tertiary care Centre in Pakistan. Pak J Med Sci. 2017; 33 (3): 554 – 549. 29. Indika NLR, Vidanapathirana DM, Dilanthi HW, Kularatnam GAM, Chandrasiri NDPD, Jasinge Eresha. Phenotypic spectrum and genetic heterogeneity of cystic fibrosis in Sri Lanka. BMC Medical Genetics 2019; 20: 89. 30. Bowler IM, Estlin EJ, Littlewood JM. Cystic Fibrosis in Asians. Arch Dis Child. 1999; 122: 1 – 9. https://doi.org/10.1186/s12881-019-0815-x: Cystic Fibrosis– Is it Extremely Rare or Invariably Missed: An Observational Study in Bangladesh Scenario 26 Year 2022 Global Journal of Medical Research Volume XXII Issue VI Version I ( D ) F © 2022 Global Journals